Analytical Data and Single-Dose PK are Sufficient to Conclude Comparable Immunogenicity for Biosimilars: An Ustekinumab Case Study. [PDF]
BioDrugsSchiestl M +6 more
europepmc +1 more source
Barriers to adoption of biosimilar insulins in Europe: A mixed-methods study. [PDF]
Diabetes Obes MetabCar E +5 more
europepmc +1 more source
Contextual factors in value-based decision support to enhance health technologies adoption: the case of biosimilars. [PDF]
Front PharmacolOtte M +10 more
europepmc +1 more source
Biosimilars in practice: Discriminant factors influencing prescription decisions among physicians in Thailand. [PDF]
PLoS OneSooksriwong C +5 more
europepmc +1 more source
The Expanding Role of Biosimilar in Autoimmune Diseases
Imtiyaz Ahmad +2 more
openalex +1 more source
Scoping review of biosimilar disease-modifying antirheumatic drugs in pregnancy: evidence gaps and proposed outcome reporting framework. [PDF]
Rheumatol IntCheng V +7 more
europepmc +1 more source
Comparative Analysis of Glycan Composition in Therapeutic Antibodies via Glycan Profiling and Intact Mass Analysis. [PDF]
MoleculesChun YS +5 more
europepmc +1 more source
Patient knowledge and acceptance of the upcoming automatic substitution of biological medicines in community pharmacies: survey of Finnish patients with inflammatory bowel disease and psoriasis. [PDF]
BMC Health Serv ResAlanne EE +4 more
europepmc +1 more source
Efficacy and Safety of Aflibercept Biosimilars Relative to Reference Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. [PDF]
Clin OphthalmolAljuhani HS +7 more
europepmc +1 more source